ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (NASDAQ: CSII): Conference Call Scheduled for Today, August 2, 2017, at 3:45 PM CT (4:45 PM ET) Revenues of $52.9 million grew 9% compared to fourth quarter last year Gross margin increased to 81.7% from 79.7% in the prior-year period Net income was $0.8 […]
Author: Ken Dropiewski
Endologix Reports Second Quarter 2017 Financial Results
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (NASDAQ:ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced financial results for the second quarter ended June 30, 2017. “While we are pleased with the overall results in the second quarter, the recovery in AFX®2 sales in the U.S. has been slower […]
4C Medical’s Novel Mitral Regurgitation Therapy Highlighted at CVI 2017 Innovation Summit
NEWS PROVIDED BY 4C Medical Technologies, Inc. 07:04 ET BROOKLYN PARK, Minn., Aug. 3, 2017 /PRNewswire/ — 4C Medical Technologies, Inc. (4C Medical), a developer of minimally invasive therapies for structural heart disease, today announced that its medical device therapy for mitral regurgitation (MR) was featured in the Innovation Summit at Cardiovascular Innovations (CVI) 2017 […]
Medtronic (MDT) Bags Approval for Avalus Valve in U.S. and Europe
DUBLIN – August 2, 2017 – Medtronic plc (NYSE: MDT) today announced CE (Conformité Européenne) mark and U.S. Food and Drug Administration (FDA) approval of its new Avalus(TM) pericardial aortic surgical valve for the treatment of aortic valve disease. The Avalus valve leverages proven surgical bioprosthetic valve concepts with added features designed to […]
Boca Raton Regional Hospital Using New Technology To Map Irregular Heart Rhythms Non-Invasively
NEWS PROVIDED BY Boca Raton Regional Hospital Aug 01, 2017, 12:24 ET BOCA RATON, Fla., Aug. 1, 2017 /PRNewswire-USNewswire/ — Boca Raton Regional Hospital is the first in Florida and one of only five centers nationally to non-invasively map irregular heartbeats in patients with chronic atrial fibrillation and other arrhythmias who have not responded adequately […]
Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures
NEWS PROVIDED BY Keystone Heart Ltd. Aug 01, 2017, 13:06 ET CAESAREA, Israel and TAMPA, Fla., Aug. 1, 2017 /PRNewswire/ — Keystone Heart Ltd., an emerging medical device company focused on developing cerebral protection devices for patients undergoing cardiac procedures, today announced plans to initiate clinical trials for a new, advanced version of Keystone Heart TriGuard™ cerebral […]
Laminate Medical Technologies Receives IDE Approval From FDA To Initiate Clinical Study Of The VasQ Device
TEL AVIV, Israel–(BUSINESS WIRE)–Laminate Medical Technologies (Laminate), an Israeli biomedical start-up developing VasQ, an implanted blood vessel external support device for patients requiring arteriovenous fistula as vascular access for hemodialysis, today announced that it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA). IDE approval […]
Want Half of Your Patients Who Smoke to Quit? Read This.
By Ken Dropiewski (ken@prime-core.com) Researchers in Denmark have once again proven the old adage that “seeing is believing.” The small study found when cardiac patients were shown images of their diseased arteries during follow-up, it influenced them to make significant and life-altering changes their diet and other habits. Want to […]
LimFlow Announces Publication Of Positive Results From Pilot Study Of Limflow Percutaneous Deep Vein Arterialization (pDVA) System
PARIS–(BUSINESS WIRE)–LimFlow SA today announced publication of positive results from the pilot study of the LimFlow Percutaneous Deep Vein Arterialization System (pDVA) in the July issue of the Journal of Endovascular Therapy. The paper is entitled “Midterm Outcomes from a Pilot Study of Percutaneous Deep Vein Arterialization for the Treatment of No-Option […]
W. L. Gore & Associates Release: GORE VIATORR TIPS Endoprosthesis With Controlled Expansion May Reduce Portal Hypertension Readmissions In Ongoing Study
FLAGSTAFF, Ariz.–(BUSINESS WIRE)–The GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion, a new device configuration developed by W. L. Gore & Associates, Inc. (Gore), may further reduce portal hypertension treatment complications, even compared to the GORE® VIATORR® TIPS Endoprosthesis, Gore’s legacy TIPS device, which has a strong history of patency and proven […]



